Clinical Trial Update: Long-Term Oral Acyclovir Usage to Prevent Herpes Zoster Virus Infection After Bone Marrow Transplant [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term oral acyclovir to prevent Varicella Zoster Virus infection after bone marrow transplantation; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster
• Varicella Zoster Virus Infection

Drugs mentioned

• ACYCLOVIR (Acyclovir)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: VZV Infection After Bone Marrow Transplantation | Phase 3 | Status: COMPLETED